课题基金 / 基金详情

项目摘要

项目成果

Julian Abrams的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Barrett’s esophagus is an increasingly prevalent, preneoplastic disorder resulting from acid/bile reflux and chronic inflammation at the GE junction. The BETRNet Research Center 1 represents a translational research program from Columbia University, the University of Pennsylvania and the Mayo Clinic. The team, which has been highly productive, has been focused on the role of microbiota and the tumor microenvironment in the development and progression of Barrett’s esophagus and esophageal adenocarcinoma. The group also includes additional collaborative sites at MIT, the Dana Farber Cancer Institute and Munich Technical University, and utilizes heavily a Microbiome and Metabolomics Core at Penn-CHOP. Thus, the team comprises broad and unique expertise in mouse models, genomics, microbiology and clinical research. Our research program is built around the hypothesis that the inflammation-dependent tumor microenvironment, modulated by the GE junction microbiome, is critical for early progression of esophageal carcinogenesis. The proposal utilizes both the novel transgenic (L2-ILB) and innovative 3D organoid models, along with a cross-sectional study of 150 Barrett’s and non-Barrett’s patients. Project 1 studied the role of microbiota and myeloid cells in the L2-ILB mouse model of Barrett’s esophagus. This project incorporated germ-free housing, antibiotic eradication, colonization with defined flora, myeloid cell ablation and correlative human studies. Project 2 focused on the characterization of microenvironment drivers in BE, and included FACS/IHC analysis of CAFs and immune cells (MDSCs/Tregs) in BE patients, along with 3D organoids in culture, as well as defining the role of IL-6 in response to epithelial TP53 mutations and immune cell activation. Finally, Project 3 seeks to identify novel biomarkers and gene signatures related to the microbiome and microenvironment. The study analyzed bile acids, a product of microbes, and minimally invasive tests such as saliva/breath test/tethered capsule sponge to analyze microbes to develop screening/surveillance strategies. Overall, these projects will advance the science of the microbiome and microenvironment in BE that will hopefully lead to translational applications. For the extension period, we propose to continue and complete experiments and analyses related to the three Projects.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
Update on ablation for Barrett's esophagus.
巴雷特食管消融的最新进展。
DOI: 10.1007/s11894-013-0368-7
发表时间: 2014
期刊: Current gastroenterology reports
影响因子: --
作者: [Falk,GaryW]
通讯作者: Falk,GaryW
DOI: 10.1016/j.giec.2010.09.013
发表时间: 2011-01
期刊: Gastrointestinal endoscopy clinics of North America
影响因子: --
作者: [Wang, Kenneth K, Okoro, Ngozi, Prasad, Ganapathy, WongKeeSong, Michel, Buttar, Navtej S, Tian, Jianmin]
通讯作者: Tian, Jianmin
Barrett's esophagus: genetic and cell changes.
巴雷特食管:遗传和细胞变化。
DOI: 10.1111/j.1749-6632.2011.06043.x
发表时间: 2011
期刊: Annals of the New York Academy of Sciences
影响因子: 5.2
作者: [Souza,RhondaF, Freschi,Giancarlo, Taddei,Antonio, Ringressi,MariaNovella, Bechi,Paolo, Castiglione,Francesca, RossiDegl'Innocenti,Duccio, Triadafilopoulos,George, Wang,JeanS, Chang,AndrewC, Barr,Hugh, Bajpai,Manisha, Das,KironM, Schneid]
通讯作者: Schneid
DOI: 10.1007/s11938-018-0171-5
发表时间: 2018-03
期刊: Current treatment options in gastroenterology
影响因子: --
作者: [May M, Abrams JA]
通讯作者: Abrams JA
12
    The Role of Secondary Bile Acids in Gastro-Esophageal Neoplasia
    The Clinical Biospecimen and Research Core
    The Clinical Biospecimen and Research Core
    The Role of Secondary Bile Acids in Gastro-Esophageal Neoplasia
    海外基金